CD44v3 and VEGF-C Expression and its Relationship with Lymph Node Metastasis in Squamous Cell Carcinomas of the Uterine Cervix |
Liu, Ye-Qing
(Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University)
Li, Hai-Feng (Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University) Han, Jing-Jing (Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University) Tang, Qiong-Lan (Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University) Sun, Qing (Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University) Huang, Zhi-Quan (Department of Oral and Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University) Li, Hai-Gang (Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University) |
1 | Su JL,Yen CJ, Chen PS, et al (2007). The role of the VEGF-C/VEGFR-3 axis in cancer progression. Br J Cancer, 96, 541-5. DOI ScienceOn |
2 | Tavassoli FA, Devilee P, et al (2003). World health organization classification of tumors. pathology and genetics of tumours of the breast and female genital organs. IARC Press: Lyon. |
3 | van der Voort R, Taher T E, Wielenga V J, et al (1999). Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met. J Biol Chem, 274, 6499-506. DOI ScienceOn |
4 | Wang SJ, Wreesmann VB, Bourguignon LY (2007). Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neckcancer. Head Neck, 29, 550-8. DOI ScienceOn |
5 | Xie LX, Zhai TT, Yang LP, et al (2013). Lymphangiog enesis and prognostic significance of vascular endothelial growth factor c in gastro-oesophageal junction adenocarcinoma. Int J Exp Pathol, 94, 39-46. DOI |
6 | Jemal A, Siegel R, Xu J, et al (2010). Cancer statistics. CA Cancer J Clin, 60, 277-300 DOI |
7 | Gombos Z, Xu X, Chu CS, et al (2005). Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix. Clin Cancer Res, 11, 8364-71. DOI ScienceOn |
8 | Hashimoto I, Kodama J, Seki N, et al (2001). Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer. Br J Cancer, 85, 93-7. DOI ScienceOn |
9 | K L Bennett, D G Jackson, J C Simon, et al (1995). D44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol, 128, 687-98. DOI ScienceOn |
10 | Kunlabut K, Vaeteewoottacharn K, Wongkham C, et al (2012). Aberrant expression of cd44 in bile duct cancer correlates with poor prognosis. Asian Pac J Cancer Prev, 13, 95-9. |
11 | Liu L, Ma X-L, Xiao ZL, et al (2012). Prognostic value of vascular endothlial growth factor expression in resected gastric cancer. Asian Pac J Cancer Prev, 13, 3089-97. DOI ScienceOn |
12 | Li Yuan, Liu Jinzhong, Zheng Yanli, et al (2009). Expressions of CD44v3 and CD54 in oral premalignant epithelia. J Pract Stomatol, 25, 694-7. |
13 | Mathur SP, Mathur RS, Gray EA, et al (2005). Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A. Gynecol Oncol, 98, 467-83. DOI ScienceOn |
14 | Banky B, Raso-Barnett L, Barbai T, et al (2012). Characteristics of CD44 alternative splice pattern in the course of human colorectal adenocarcinoma progression. Mol Cancer, 11, 83. DOI |
15 | Branca M, Giorgi C, Santini D, et al (2006). Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer. J Clin Pathol, 59, 40-7. DOI ScienceOn |
16 | Duan L, Ye L, Zhao G, et al (2012). Serum spleen tyrosine kinase and vascular endothelial growth factor-C levels predict lymph node metastasis of oesophageal squamous cell carcinoma. Eur J Cardiothorac Surg. |
17 | Zhongliang Wang, Yao Chen, Xiaofeng Li, et al (2012). Expression of VEGF-C/VEGFR-3 in human laryngeal squamous cell carcinomas and its significance for lymphatic metastasis. Asian Pac J Cancer Prev, 13, 27-31. 과학기술학회마을 DOI ScienceOn |
18 | Fox S B, Gatter K C, Jackson D G, et al (1993). CD44 and cancer screening. Lancet, 342, 548-9. DOI ScienceOn |
19 | Gotley D C, Fawcett J, Walsh M D, et al (1996). Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer. Br J Cancer, 74, 342-51. DOI ScienceOn |
20 | Schlessinger J, Lax I, Lemmon M (1995). Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors? Cell, 83, 357-60. DOI ScienceOn |
21 | Naor D, Wallach-Dayan SB, Zahalka MA, et al (2008). Involvement of CD44, a molecule with a thousand faces, in cancer dissemination. Semin Cancer Biol, 18, 260-7. DOI ScienceOn |
22 | Roye GD, Myers RB, Brown D, et al. CD44 expression in dysplastic epithelium and squamous-cell carcinoma of the esophagus. Int J Cancer, 69, 254-8. |
23 | SpeiserP, Wanner C, Tempfer C, et al (1997). CD44 is an independent prognostic factor in early-stage cervical cancer. Int J Cancer, 74, 185-8. DOI |
24 | Tawfik OW, Kramer B, Shideler B, et al (2007). Prognostic significance of CD44, platelet-derived growth factor receptor alpha, and cyclooxygenase 2 expression in renal cell carcinoma. Arch Pathol Lab Med, 131, 261-7. |
25 | Inoue A, Moriya H, Katada N, et al (2008). Intratumoral lymphangiogenesis of esophageal squamous cell carcinoma and relationship with regulatory factors and prognosis. Pathol Int, 58, 611-9. DOI ScienceOn |
![]() |